Prosight Management, LP Sio Gene Therapies Inc. Transaction History

Prosight Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.25 - $0.73 $167,575 - $489,319	-670,300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.55 - $1.47 $72,534 - $193,863	-131,880 Reduced 16.44%	670,300 $449,000
Q4 2021 Feb 14, 2022	BUY	$1.29 - $2.36 $398,573 - $729,173	308,972 Added 62.65%	802,180 $1.04 Million
Q3 2021 Nov 12, 2021	BUY	$1.81 - $2.7 $429,138 - $640,151	237,093 Added 92.57%	493,208 $1.07 Million
Q2 2021 Aug 13, 2021	BUY	$2.07 - $2.89 $103,945 - $145,121	50,215 Added 24.39%	256,115 $699,000
Q1 2021 May 14, 2021	BUY	$2.34 - $3.44 $481,805 - $708,296	205,900 New	205,900 $537,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.